OSCR

Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.

Overview

Authors: Ye Tan1, Fengyu Cheng2, Pu Li3, Jingxuan Xiang4, Yuhong Tang1, Aidong Chen4, Peiying Han5
ORCID iDs: Ye Tan
  1. Department of Clinical Medicine, Kangda College of Nanjing Medical University, Lianyungang, China
  2. The First People’s Hospital of Lianyungang, The Lianyungang Clinical College of Nanjing Medical University, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, China
  3. Department of Orthopedics, Siyang First People’s Hospital, Suqian, China
  4. The Key Laboratory of Targeted Intervention of Clinical Disease, Nanjing Medical University, Nanjing, China
  5. Nursing Department, Nanjing Drum Tower Hospital, Nanjing, China
Institutions: Kangda College of Nanjing Medical University; Xuzhou Medical College (China); Nanjing Medical University (China); Nanjing Drum Tower Hospital (China)
Journal: Epigenomics, volume 18, issue 7, pages 781-790
Dates: published online 19 June 2026; in print July 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1080/17501911.2026.2691031 · PMID 42318604 · PMCID PMC13390522 · OpenAlex W7165148567
Open access: hybrid, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), human (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics, Preprocessing, Connectivity
Keywords: Glioblastoma, brain-enriched long noncoding RNA, promoter methylation, methylation-expression association, public-data re-analysis, single-cell validation
MeSH: Brain Neoplasms*, DNA Methylation*, Glioblastoma*, Promoter Regions, Genetic*, RNA, Long Noncoding*, Brain, Epigenesis, Genetic, Epigenomics, Gene Expression Regulation, Neoplastic, Humans (* major topic)
Topic: Cancer-related molecular mechanisms research (Cancer Research, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: Aid Project of Jiangsu Ningai Medical Development and Medical Aid Foundation (NDYGN2025065)
Citations: not cited yet (Europe PMC); 34 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • no repository, dataset or request procedure was recognized in it

Read it in the paper: doi.org/10.1080/17501911.2026.2691031.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 6 keywords, 10 MeSH terms, 1 funder, 33 references.

Cite

This paper

Tan, Y., Cheng, F., Li, P., Xiang, J., Tang, Y., Chen, A., & Han, P. (2026). Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis. Epigenomics, 18(7), 781-790. https://doi.org/10.1080/17501911.2026.2691031

BibTeX

@article{tan2026promoter,
author = {Tan, Ye and Cheng, Fengyu and Li, Pu and Xiang, Jingxuan and Tang, Yuhong and Chen, Aidong and Han, Peiying},
title = {{Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis}},
journal = {Epigenomics},
year = {2026},
month = jun,
volume = {18},
number = {7},
pages = {781--790},
publisher = {Taylor \& Francis},
issn = {1750-1911},
doi = {10.1080/17501911.2026.2691031},
url = {https://doi.org/10.1080/17501911.2026.2691031},
pmid = {42318604},
pmcid = {PMC13390522}
}

RIS

TY - JOUR
AU - Tan, Ye
AU - Cheng, Fengyu
AU - Li, Pu
AU - Xiang, Jingxuan
AU - Tang, Yuhong
AU - Chen, Aidong
AU - Han, Peiying
TI - Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis
T2 - Epigenomics
J2 - Epigenomics
PY - 2026
DA - 2026/06/19
VL - 18
IS - 7
SP - 781
EP - 790
SN - 1750-1911
PB - Taylor & Francis
DO - 10.1080/17501911.2026.2691031
UR - https://doi.org/10.1080/17501911.2026.2691031
LA - en
ER -

CSL-JSON

{
"id": "10.1080/17501911.2026.2691031",
"type": "article-journal",
"title": "Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis",
"container-title": "Epigenomics",
"author": [
{
"family": "Tan",
"given": "Ye"
},
{
"family": "Cheng",
"given": "Fengyu"
},
{
"family": "Li",
"given": "Pu"
},
{
"family": "Xiang",
"given": "Jingxuan"
},
{
"family": "Tang",
"given": "Yuhong"
},
{
"family": "Chen",
"given": "Aidong"
},
{
"family": "Han",
"given": "Peiying"
}
],
"container-title-short": "Epigenomics",
"volume": "18",
"issue": "7",
"page": "781-790",
"DOI": "10.1080/17501911.2026.2691031",
"PMID": "42318604",
"PMCID": "PMC13390522",
"ISSN": "1750-1911",
"publisher": "Taylor & Francis",
"URL": "https://doi.org/10.1080/17501911.2026.2691031",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
19
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/cancers18162616
Decitabine Reprograms Temozolomide-Resistant Glioblastoma Through Epigenetic Reactivation and Mesenchymal Attenuation: A Multi-Omics Study.
Journal: Cancers
In common: genetics / omics, other condition, 6 references
[2] doi:10.3390/cancers18132092
TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activated Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study.
Journal: Cancers
In common: genetics / omics, other condition, 6 references
[3] doi:10.3390/ijms27167240
1-Piperidine Propionic Acid Inhibits PAR2/SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness.
Journal: International journal of molecular sciences
In common: other condition, cellular / molecular, 5 references
[4] doi:10.1016/j.xcrm.2026.102766 [code]
A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma.
Journal: Cell reports. Medicine
In common: genetics / omics, other condition, cellular / molecular, 4 references
[5] doi:10.1371/journal.pone.0351405 [code]
Unimodal vs. multimodal deep learning for non-invasive MGMT promoter methylation prediction in glioblastoma: A systematic evaluation on the BraTS 2021 dataset.
Journal: PloS one
In common: genetics / omics, other condition, 4 references
[6] doi:10.3390/ijms27136068 [code]
Loss of Neuropeptide Y Signaling Accompanies the Neural-to-Mesenchymal Transcriptional Transition in Glioblastoma: A Multi-Scale Transcriptomic Analysis.
Journal: International journal of molecular sciences
In common: genetics / omics, other condition, cellular / molecular, 4 references
[7] doi:10.32604/or.2026.079221
Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.
Journal: Oncology research
In common: genetics / omics, other condition, cellular / molecular, 4 references
[8] doi:10.1186/s40478-026-02318-7
Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 4 references
[9] doi:10.1016/j.isci.2026.115875
Role of NR2F2-mediated reprogramming of endothelial cells in glioblastoma progression.
Journal: iScience
In common: genetics / omics, other condition, cellular / molecular, 4 references
[10] doi:10.1093/neuonc/noaf257
Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a Phase 0/1 trial of recurrent high-grade glioma.
Journal: Neuro-oncology
In common: genetics / omics, other condition, 4 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.